Sign in
Stories
Investor Lawsuits and Investigations Unfold
Share
Legal Actions Shake Markets
Legal Battles and Dismissals: Corporate ...
Legal Firms Initiate Class Actions
Amylyx Pharmaceuticals Faces Lawsuit
BioNTech Faces Securities Lawsuit
BioNTech Investors Alert: Lawsuit Potent...
Overview
API
Investor counsel firms, such as Rosen Law Firm and Bragar Eagel & Squire, are actively involved in investigations and lawsuits against BioVie Inc., BioNTech SE, and Biogen Inc. for alleged misleading statements, false information, and violations of securities laws, particularly related to their business operations during the COVID-19 pandemic.
Ask a question
How might these legal actions impact the reputation and market perception of the pharmaceutical companies involved?
In what ways could these investigations influence investor confidence in the pharmaceutical industry as a whole?
What measures can pharmaceutical companies take to ensure transparency and compliance with securities laws amidst growing scrutiny?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Feb 2024
Coverage